The global biological safety testing products and services market size was valued at USD 5.26 billion in 2025 and is projected to grow from USD 5.82 billion in 2026 to USD 13.11 billion by 2034, registering a CAGR of 10.68% during the forecast period from 2026 to 2034. North America dominated the biological safety testing products and services market with a market share of 42.5% in 2025.
Biological safety testing products and services include specialized solutions used to evaluate the safety, purity, potency, and quality of pharmaceuticals, biologics, vaccines, cell and gene therapies, and medical devices before commercialization. These products and services help detect contaminants, microorganisms, endotoxins, and other biological risks while ensuring compliance with regulatory standards. Demand is driven by the expanding biopharmaceutical industry, increasing biologics production, and stringent global quality and safety requirements.
Download a Free Sample To learn more about this report,
Increasing Adoption of Advanced and Rapid Biological Safety Testing Technologies
The biological safety testing products and services market is increasingly adopting advanced analytical technologies designed to improve the speed, sensitivity, and reliability of safety testing workflows. Rapid microbiological methods, molecular techniques, and automated testing platforms are helping laboratories identify potential contaminants more efficiently. This trend is supporting the modernization of biological safety testing across pharmaceutical, biotechnology, and medical product development activities.
In March 2025, life sciences testing providers continued advancing rapid and technology-enabled approaches designed to improve the efficiency and analytical capabilities of biological safety testing workflows.
Growing Outsourcing of Biological Safety Testing Services
Pharmaceutical and biotechnology companies are increasingly relying on specialized contract testing organizations for biological safety assessments. Outsourcing can provide access to specialized expertise, advanced laboratory infrastructure, and regulatory knowledge without requiring companies to develop all testing capabilities internally. The growing complexity of product development and quality requirements is supporting demand for specialized biological safety testing services.
In July 2025, pharmaceutical and biotechnology organizations continued expanding the use of specialized external testing services to support product development, quality assurance, and biological safety requirements.
Increasing Regulatory Focus on Product Safety and Quality Compliance
Pharmaceutical, biotechnology, and medical product manufacturers must conduct rigorous testing to demonstrate that products meet applicable biological safety and quality requirements. Regulatory expectations regarding contamination control, sterility, microbial safety, and product quality are encouraging organizations to adopt specialized testing products and services. The need to maintain compliance throughout product development and manufacturing therefore provides a fundamental driver for market growth.
In April 2025, life sciences manufacturers continued strengthening quality-control and biological safety testing practices to support regulatory compliance and product safety requirements.
High Cost of Specialized Testing Infrastructure and Services
Advanced biological safety testing can require sophisticated laboratory equipment, controlled testing environments, specialized reagents, and highly trained personnel. Comprehensive testing programs may also involve significant operational and service costs. These financial requirements can create challenges for smaller biotechnology companies and research organizations with limited budgets.
In June 2025, life sciences organizations continued managing the substantial infrastructure and operational costs associated with maintaining advanced quality-control and biological safety testing capabilities.
Expansion of Biologics and Advanced Therapy Development
The growing development of biologics, cell therapies, gene therapies, and other advanced therapeutic products is creating new opportunities for biological safety testing providers. These complex products can require specialized testing throughout development and manufacturing to evaluate contamination risks and product safety. The expansion of advanced biopharmaceutical development therefore represents an important growth opportunity for providers of specialized testing products and services.
In September 2025, biotechnology and pharmaceutical organizations continued expanding development activities involving biologics and advanced therapies requiring specialized safety and quality testing capabilities.
Managing Complex and Evolving Testing Requirements
Biological safety testing requirements can vary depending on product type, manufacturing process, biological materials, and applicable regulatory expectations. Testing providers must continuously adapt their capabilities to address evolving technologies and increasingly complex therapeutic products. Maintaining scientific expertise, validated methods, and regulatory readiness across diverse testing requirements remains a significant challenge for market participants.
In November 2025, biological safety testing organizations continued strengthening technical expertise and analytical capabilities to address increasingly complex product development and regulatory testing requirements.
Reagents & Kits Segment Dominated the Market with 48.6% Share in 2025
The reagents & kits segment dominated the global biological safety testing products and services market with a 48.6% share in 2025, driven by their extensive use in routine quality control, contamination detection, and regulatory compliance testing during biopharmaceutical development and manufacturing. The growing production of biologics, vaccines, and cell-based therapies continues to support strong demand for reliable and standardized testing kits.
The services and instruments segments are witnessing steady growth as biopharmaceutical companies increasingly outsource biological safety testing while investing in advanced analytical equipment to improve testing accuracy and operational efficiency. Rising regulatory requirements and the need for faster product approvals continue to drive demand across both segments.
Continuous advancements in automated testing platforms, high-throughput screening technologies, and specialized laboratory services are expected to further strengthen market growth. Increasing investments in biologics manufacturing and quality assurance programs continue to create opportunities for both instruments and service providers.
Request Customizationto receive a tailored report.
Vaccines & Therapeutics Segment Dominated the Market with 44.2% Share in 2025
The vaccines & therapeutics segment dominated the global Biological Safety Testing Products and Services Market with a 44.2% share in 2025, supported by the increasing development of biologics, vaccines, and advanced therapeutic products requiring stringent safety evaluation. Growing regulatory oversight and the expansion of biopharmaceutical production continue to reinforce the segment's leading position.
The vaccines, monoclonal antibodies, recombinant protein, and blood & blood-based products segments are expanding steadily as manufacturers focus on ensuring product safety, purity, and consistency throughout the development and commercialization process. Increasing investments in immunotherapies, plasma-derived products, and recombinant biologics continue to drive testing demand across these applications.
The gene therapy, stem cell, and tissue & tissue-based products segments are witnessing rapid growth due to the rising adoption of regenerative medicine and next-generation cell and gene therapies. As these advanced therapies become more widely developed and commercialized, the need for comprehensive biological safety testing is expected to increase significantly.
Endotoxin Tests Segment Dominated the Market with 20.4% Share in 2025
The endotoxin tests segment dominated the global Biological Safety Testing Products and Services Market with a 20.4% share in 2025, driven by the critical need to detect bacterial endotoxins in biologics, vaccines, injectable drugs, and medical devices. Strict regulatory requirements and the importance of ensuring patient safety continue to support widespread adoption of endotoxin testing.
The sterility tests, cell line authentication & characterization tests, and adventitious agent detection tests are witnessing steady growth as manufacturers strengthen quality control processes and regulatory compliance. At the same time, bioburden tests and residual host contamination detection tests continue to gain importance in identifying microbial contamination and impurities during biologics manufacturing.
The others segment is also expanding steadily with the introduction of advanced biological safety assessment methods designed to address emerging therapeutic modalities. Continuous innovation in testing technologies, automation, and rapid detection platforms is expected to enhance efficiency and support growing demand across all test categories.
Speak to an Analystto discuss market opportunities.
North America biological safety testing products and services market accounted for 42.5% of the global market, reaching USD 2.24 billion in 2025, and is projected to grow at a CAGR of 12.4% during the forecast period. Strong biopharmaceutical manufacturing, increasing biologics and vaccine development, and strict regulatory requirements for product safety continue to drive regional market growth. Rising investments in quality assurance and laboratory testing services are also supporting market expansion.
The U.S. market was valued at USD 1.90 billion in 2025, making it the largest contributor in North America. Expanding biologics production, increasing clinical research activities, and growing demand for regulatory compliance testing continue to strengthen market growth.
Canada's market reached USD 0.34 billion in 2025. Rising investments in biotechnology research, expanding pharmaceutical manufacturing, and increasing adoption of advanced biological safety testing solutions continue to support steady market expansion.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe biological safety testing products and services market accounted for 28.3% of the global market, reaching USD 1.49 billion in 2025, and is expected to register a CAGR of 11.9% during the forecast period. Growing biologics production, increasing regulatory scrutiny, and rising investments in pharmaceutical quality control are driving regional growth. Expanding contract testing services are also contributing to market development.
Germany's market accounted for USD 0.43 billion in 2025. A strong pharmaceutical manufacturing base, increasing biologics development, and growing demand for high-quality laboratory testing continue to support market growth.
The UK market was valued at USD 0.30 billion in 2025. Rising investments in life sciences, expanding clinical research, and increasing outsourcing of biological safety testing continue to contribute to market expansion.
Asia Pacific biological safety testing products and services market accounted for 20.7% of the global market, valued at USD 1.09 billion in 2025, and is projected to register a CAGR of 14.6% during the forecast period. Expanding biopharmaceutical manufacturing, increasing vaccine production, growing biotechnology investments, and supportive government initiatives continue to accelerate regional market growth.
Japan's market generated USD 0.20 billion in 2025. Increasing biologics research, growing pharmaceutical innovation, and continuous investments in quality testing technologies continue to support market growth.
China's market accounted for USD 0.57 billion in 2025, representing the largest share within Asia Pacific. Rapid expansion of biopharmaceutical manufacturing, increasing clinical trials, and rising demand for regulatory testing services continue to drive market expansion.
Latin America biological safety testing products and services market accounted for 5.1% of the global market, reaching USD 0.27 billion in 2025, and is projected to grow at a CAGR of 11.2% during the forecast period. Growing pharmaceutical production, increasing healthcare investments, and rising demand for quality assurance services continue to support regional market growth.
Brazil's market reached USD 0.14 billion in 2025. Expanding pharmaceutical manufacturing, increasing biotechnology research, and growing adoption of biological safety testing services continue to create growth opportunities across the country.
Middle East & Africa biological safety testing products and services market accounted for 3.4% of the global market, totaling USD 0.18 billion in 2025, and is anticipated to grow at a CAGR of 10.7% during the forecast period. Increasing investments in pharmaceutical manufacturing, expanding healthcare infrastructure, and growing focus on product quality and regulatory compliance are supporting regional market growth.
The UAE market was valued at USD 0.06 billion in 2025. Rising investments in biotechnology, expanding pharmaceutical production capabilities, and increasing adoption of international quality standards continue to drive market growth.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
India Pharmaceutical Stability and Storage Services Market Size, Share & Trends | Industry Report, 2034
Healthcare Regulatory Affairs Outsourcing Market Size, Share, 2034
Facial Fat Transfer Market Size, Share, Growth, Analysis, 2034
Viral Vector Manufacturing Market Size, Share, Growth, Analysis, 2034
Medical Equipment Rental Market Size, Share, Growth, 2034
Pharmaceutical Stability and Storage Services Market Size, 2034
We are featured on:
sales@straitsresearch.com